Stocks are bleeding as corona virus fears increase. This outbreak has investors worried about whether this will become a new pandemic.
A pandemic will rattle the global economy and may lead to a recession deeper than the 2008/2009 global financial crisis. This will also lead to the collapse of basic necessities leading to a global supply chain seize.
There is now 79,500 reported cases on the corona virus (COVOID-19) in 32 countries and 2,622 deaths with the appearance of slowing down in China. 47 cases and 12 deaths appeared in Iran and 124 cases with 2 deaths in Italy, therefore making corona virus (COVOID-19) a valid global pandemic.
The World Health Organization has shared new findings that in China, the fatality rate is between 2 to 4 percent with SARS being 10 percent. Recovery times is expected to be around 2 weeks.
Corona Virus’ Impact on Stocks
• L’Oréal told investors that the impact from the outbreak will be temporary, based on the cosmetics maker’s experience with the outbreaks of SARS in 2003 and Middle East respiratory syndrome (MERS) in 2015. What is different about this outbreak, however, is L’Oréal’s e-commerce sales of beauty products in China are stronger so far in February than they were this month last year. “This crisis will even strengthen the position of the e-commerce players in China,” CEO Jean-Paul Agon told investors on Monday at an analyst conference.
• Ascential PLC (ASCL), an events company, told investors that Chinese investors make up less than 5% of its revenue and only 2% of attendees at the Cannes Lions International Festival of Creativity, an annual advertising event held in June in the south of France. The company said it has not seen a material impact from the outbreak. “I do think it is too early for us to say anything other than we don’t expect from what we know today, any major impact on our major events,” an executive said on its earnings call.
• The Biotechnology Innovation Organization canceled the annual BIO Asia conference in Tokyo, which was scheduled to take place March 10 and 11 over COVID-19 concerns.
• Trip.com (TCOM), a Shanghai-based travel services company, rescheduled its fourth-quarter and full-year earnings to March 18 “due to the evolving situation brought on by the novel coronavirus outbreak in China.”
• Shares of Zoom Video Communications Inc. (ZM), are up more than 6% in Monday trading amid COVID-19. Zoom markets software that allows employees to conduct video-conference meetings and otherwise engage in remote work, and the stock has surged at times during the coronavirus outbreak on the expectation that more countries and companies would urge employees to work from home, thus creating new demand for remote-work tools.
2 Stocks We Recommend You Buy
- Aptose Biosciences (APTO) $8.20 – Highly under valued stock, has potential to be bought out and showing similar signs like ArQule (ARQL) with it’s BTK Inhibitor.
- Sunesis Pharmaceuticals (SNSS) $0.87 – Highly valued candidate “Vecabrutinib” has the ability to be combined to make combos with other therapies for better results like with a combo of Vecabrutinib and a Kinase Inhibitor to target Car-T, also has potential for acquisition.
